Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott K Thompson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonistsYonghui Wang, Chaya Duraiswami, Kevin P Madauss, et al.
Molecular Endocrinology (Baltimore, Md.)|March 16, 2007
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulatorKevin P Madauss, Eugene T Grygielko, Su-Jun Deng, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonistsScott K Thompson, David G Washburn, James S Frazee, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonistsMarlys Hammond, Jaclyn R Patterson, Sharada Manns, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonistsDavid G Washburn, Tram H Hoang, James S Frazee, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2009
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitorsMarlys Hammond, David G Washburn, H Tram Hoang, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Journal of Lipid Research|July 19, 2005
Synthetic LXR agonists increase LDL in CETP speciesPieter H E Groot, Nigel J Pearce, John W Yates, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
Improving the developability profile of pyrrolidine progesterone receptor partial agonistsLara S Kallander, David G Washburn, Tram H Hoang, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivoLara S Kallander, Qing Lu, Wenfang Chen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|August 12, 2009
2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonistsYonghui Wang, Chaya Duraiswami, Kevin P Madauss, et al.
Molecular Endocrinology (Baltimore, Md.)|March 16, 2007
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulatorKevin P Madauss, Eugene T Grygielko, Su-Jun Deng, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonistsScott K Thompson, David G Washburn, James S Frazee, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonistsMarlys Hammond, Jaclyn R Patterson, Sharada Manns, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonistsDavid G Washburn, Tram H Hoang, James S Frazee, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2009
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitorsMarlys Hammond, David G Washburn, H Tram Hoang, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Journal of Lipid Research|July 19, 2005
Synthetic LXR agonists increase LDL in CETP speciesPieter H E Groot, Nigel J Pearce, John W Yates, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
Improving the developability profile of pyrrolidine progesterone receptor partial agonistsLara S Kallander, David G Washburn, Tram H Hoang, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivoLara S Kallander, Qing Lu, Wenfang Chen, et al.
Pageof 3